Key Takeaways
- Axis Bank infuses ₹1,612 crore for 19.02% stake: The capital infusion, priced at fair market value via DCF, strengthens Max Life’s solvency and funds growth ambitions for the next 18–24 months, with a path to 20% ownership.
- APE growth held back by banca base effects: Proprietary channels grew 23% APE and retail protection surged 36%, but overall growth was muted as the Axis Bank channel faced a tough base effect and open-architecture disruption that management now calls stabilized.
- Margin expansion undershot the mix improvement: New business margin rose 110 bps YoY to 22.2%, well below what the shift toward higher-margin protection and non-par would imply, because new initiative costs and curve movements created a “fairly substantial drag.”
- Full-year margin guided down to 27–28%: Management is explicitly prioritizing growth investments over margin maximization this year, with proprietary channel expansion, new offices, and banca capacity build-out absorbing the benefit of product-mix improvement.
- What to watch next quarter: Whether the promised Q2 growth rebound above 20% materializes as banca counters fire again, and whether pricing actions on non-par products begin to close the gap between mix improvement and reported margin.
Axis Bank Capital Infusion & Ownership Path
- Deal structure: Axis Bank will subscribe to equity shares of Max Life at fair market value determined by DCF methodology, infusing ₹1,612 crore. Post-subscription, Axis entities will collectively hold 19.02% of Max Life, with an additional right to acquire a further 0.98% stake from MFSL. The transaction requires shareholder, IRDAI, PFRDA and CCI approvals.
- Strategic rationale: The capital infusion improves Max Life’s solvency margin and funds growth in capital-intensive protection and annuity lines for at least 18–24 months. Axis Bank saw value in coming in at fair market value rather than at a discount, reflecting the franchise’s long-term potential.
- Path to 20%: Management’s stated objective is to reach 20% Axis ownership “as soon as possible,” with the current tranche as a sequenced step. The remaining ~1% will be a secondary acquisition from MFSL, not a primary infusion.
- Timeline: The current transaction is expected to close in 3–6 months, subject to regulatory approvals. The reverse merger of Max Life into the listed entity is estimated at a further 18–22 months after that, putting total completion roughly 2.5 years out.
- Counter-share expectations: Axis Bank’s share of Max Life’s business is expected to remain range-bound between 65–70%, or 70% plus/minus two percentage points, with no material change anticipated from the stake increase.
Tripathy: “The objective definitely is to go up to 20% as soon as possible. So we are moving sequenced. And there is no agenda here, honestly.”
Distribution: Banca Stabilization & Proprietary Momentum
- Banca channel decline was structural, not competitive: Bank channel APE fell 2% YoY, driven entirely by a large base effect at Axis Bank and sluggish counter-level growth, not by loss of counter share. Open architecture at the two largest counters (Axis and YES Bank) disrupted growth over the past 12–15 months, but that phase has now stabilized as all players who needed to join have done so.
- Proprietary channels delivered 23% APE growth: Online e-commerce grew 44% on market leadership in protection and share gains in savings, while offline proprietary channels grew 18% fueled by new agent activations, adviser recruitment, and a new cross-sell channel.
- New partnerships are small today, material over time: Six new partners were onboarded in Q1, including South Indian Bank and five brokers/corporate agents. Over the past 7–8 months, Max Life has signed five small-to-medium banks and 10 of the largest brokers. Management expects these new relationships to contribute close to 6–7% of sales in about four years, though near-term volumes remain small.
- Investment posture: Max Life plans to establish 100 new offices this year and is deploying more people on bancassurance counters, with resources at Axis Bank up 26% YoY. These investments are a deliberate drag on current margins in exchange for future growth.
Tripathy: “I think my narrative will be the tough phase on banca seems to be coming to an end. And I think, with the momentum that we are seeing on proprietary channel, with our banks firing, I think Max Life Insurance’ performance on new sales will continuously improve.”
Product Mix & Margin Dynamics
| Product Line | APE Trend | Margin Implication |
|---|---|---|
| Non-Par Savings | 41% of mix; consciously rebalanced down from 40%+ last year toward a 30–35% steady state | Pricing actions taken to reduce IRR in line with interest curves; mix shrinkage will pressure margins |
| Participating (Par) | 20% of mix; new SWAG Par launched in June with flexibility options | Par portfolio margins expected to improve at an aggregate level |
| ULIPs | 29% of mix; new ULIP design being launched selectively | Proportion expected to increase, contributing to growth |
| Retail Protection | 36% APE growth, better than expected | Higher-margin line; growth trajectory expected to remain high through the year |
| Annuity | 260% APE growth, driven by granular group annuities | Margin profile slightly below company average but VNB-accretive |
- The margin puzzle: Despite a roughly 1,100 bps mix shift toward higher-margin non-par and protection, new business margin expanded only ~110 bps YoY to 22.2%. Management attributed the gap to two factors: new initiatives and capacity built over the last 6–8 months creating a “fairly substantial drag,” and underlying variant mix and curve movements during the quarter. Pricing actions have been taken to correct some of these effects, but no quantification or reconciliation was provided.
- Full-year margin guidance held at 27–28%: Management reaffirmed the beginning-of-year guidance, explicitly stating a bias toward driving growth over maximizing margin this year. Investments in proprietary channels, office openings, underwriting capacity, and banca deployment will keep margins below last year’s level.
Tripathy: “The guidance on margin actually stays, which I gave at the beginning of the year, that we should look at margins for the full year lower than how it was last year. We have given guidance of between 27% to 28%. I also highlighted quite clearly that, at least for this year, there’ll be a bias towards driving growth, as against maximizing the margin.”
Protection & Annuity: The Two Growth Bets
- Retail protection surged 36%: Growth was driven by both demand-side recovery (post-COVID search queries up, more buyers entering the market) and supply-side improvements (buffered underwriting capacity, a new reinsurance partner onboarded, and greater flexibility on sum assured, customer types, and city coverage). Management expects the high growth trajectory to continue through the year.
- Annuity grew 260% APE: The growth was led by group annuities but is granular across corporate, retail individual, and NPS annuity segments. A dedicated holistic retirements team now taps all three sub-markets. While the margin profile is slightly lower than the company average, the business is both VNB-accretive and margin-accretive.
- Capital intensity is the binding constraint: Both protection and annuity require higher initial capital than savings products, which is why the Axis Bank capital infusion is strategically timed. Management’s medium-term aspiration is to become dominant in both categories, targeting 20%+ growth over a three-to-four-year horizon.
- Credit life acceleration: The credit life segment grew 27% and is expected to accelerate further, supported by new partner acquisitions, higher aggression, and regulatory flexibilities that enhance Max Life’s ability to compete.
Digital & Operational Initiatives
- mSMART rollout: A sales management and activity-monitoring tool has been fully launched across all channels, aimed at improving adviser productivity and visibility.
- Underwriting automation: An AI engine for auto financial underwriting in the self-employed segment now uses financial surrogates from bureau data, third-party data, and account aggregators. Business insurance issuance has been fully digitized.
- Customer-journey digitization: Digital living certifications enable seamless customer-driven journeys, NPS onboarding has been expedited via PRAN integration, and the Account Aggregator framework is now accepted as a valid income surrogate for salaried customers. FATCA and NEFT enablement on the website now serves NRI customers.
- IFRS implementation underway: Max Life is one of the model companies the regulator is pushing for early adoption. A core team is working on it with KPMG, though no timeline was specified.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Full-year growth | Double-digit growth rate for FY24; Q2 target of 20%+ APE growth | FY24, with Q2 as the inflection point |
| Medium-term growth aspiration | 20% growth target | 3–4 years |
| Full-year new business margin | 27–28% | FY24 |
| Axis Bank stake increase to 20% | Current tranche (19.02%) closes, then residual ~1% acquired from MFSL | Current tranche: 3–6 months; path to 20%: “as soon as possible” |
| Reverse merger of Max Life into listed entity | Completion of the merger process | ~2.5 years total (18–22 months after current transaction closes) |
| Non-par product mix | Steady around 30–35% of mix | FY24 |
| New relationship contribution | New bank, broker, and corporate agent partnerships to reach ~6–7% of sales | ~4 years |
| Proprietary channel investment | 100 new offices established | FY24 |
| Banca channel recovery | Axis channel performance to start improving; tough phase ending | Starting this month (Q2 FY24) |
Key Metrics
| Metric | Q1 FY24 |
|---|---|
| Consolidated revenue (excl. investment income) | ₹4,730 cr, +19% YoY |
| Consolidated PAT | ₹101 cr, +48% YoY |
| Gross premium (Max Life) | ₹4,871 cr, +19% YoY |
| Renewal premium (Max Life) | ₹3,014 cr, +15% YoY |
| New business premium growth | 25% YoY |
| Total APE growth | 10% YoY |
| Value of new business (VNB) | ₹247 cr, +16% YoY from ₹213 cr |
| New business margin | 22.2%, +110 bps YoY from 21.1% |
| Embedded value (Max Life) | ₹16,938 cr, operating RoEV of 14% |
| Standalone PAT (Max Life) | ~₹89 cr |
| Standalone pre-tax profit (Max Life) | ₹103 cr, +14% YoY |
| Solvency ratio (Max Life) | 188% |
| AUM (Max Life) | ~₹1.29 lakh cr, +21% YoY |
| Policyholder opex-to-GWP | 17.4% |
| Product mix: PAR / Non-PAR savings / ULIP / Protection | 20% / 41% / 29% / 10% |
| Retail protection APE growth | 36% YoY |
| Annuity APE growth | 260% YoY |
| Credit life growth | 27% YoY |
| Proprietary channels APE growth | 23% YoY |
| Bank channels APE growth | -2% YoY |
| Axis Bank contribution to sales | 51% to 57% |
| 13th month persistency (Regular/Limited pay premium) | 84% |
| 61st month persistency | 51% |
| Net Promoter Score | 53, up from 52 in March 2023 |
| Max Life Pension AUM | ~₹293 cr as of June 30, 2023 |
| Economic variance in EV | ₹133 cr |
| Resources deployed with Axis Bank | 26% higher YoY |